ClinicalTrials.Veeva

Menu

Montelukast Compared With Placebo and Salmeterol in Exercise-Induced Bronchoconstriction (0476-316)

Organon logo

Organon

Status and phase

Completed
Phase 3

Conditions

Asthma, Exercise-Induced

Treatments

Drug: Comparator: Montelukast
Drug: Comparator: Salmeterol
Drug: Comparator: Placebo (salmeterol)
Drug: Comparator: Placebo (montelukast)

Study type

Interventional

Funder types

Industry

Identifiers

NCT00245570
0476-316
2005_043
MK0476-316

Details and patient eligibility

About

To determine the effect of an approved medication being studied in support of a new approach in the prevention of exercise-induced asthma (a worsening of asthma caused by exercise, also known as exercise-induced bronchospasm), in patients who have a history of worsening asthma after exercise.

Enrollment

47 patients

Sex

All

Ages

15 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Physician-diagnosed exercise-induced bronchospasm

Exclusion criteria

  • Patient is, other than asthma, not in good, stable health. The Primary Investigator will evaluate whether there are other reasons why the patient may not participate.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

47 participants in 6 patient groups

1
Experimental group
Description:
Montelukast - Salmeterol - Placebo
Treatment:
Drug: Comparator: Salmeterol
Drug: Comparator: Placebo (salmeterol)
Drug: Comparator: Placebo (montelukast)
Drug: Comparator: Montelukast
2
Experimental group
Description:
Montelukast - Placebo - Salmeterol
Treatment:
Drug: Comparator: Salmeterol
Drug: Comparator: Placebo (salmeterol)
Drug: Comparator: Placebo (montelukast)
Drug: Comparator: Montelukast
3
Experimental group
Description:
Salmeterol - Montelukast - Placebo
Treatment:
Drug: Comparator: Salmeterol
Drug: Comparator: Placebo (salmeterol)
Drug: Comparator: Placebo (montelukast)
Drug: Comparator: Montelukast
4
Experimental group
Description:
Salmeterol - Placebo - Montelukast
Treatment:
Drug: Comparator: Salmeterol
Drug: Comparator: Placebo (salmeterol)
Drug: Comparator: Placebo (montelukast)
Drug: Comparator: Montelukast
5
Experimental group
Description:
Placebo - Montelukast - Salmeterol
Treatment:
Drug: Comparator: Salmeterol
Drug: Comparator: Placebo (salmeterol)
Drug: Comparator: Placebo (montelukast)
Drug: Comparator: Montelukast
6
Experimental group
Description:
Placebo - Salmeterol - Montelukast
Treatment:
Drug: Comparator: Salmeterol
Drug: Comparator: Placebo (salmeterol)
Drug: Comparator: Placebo (montelukast)
Drug: Comparator: Montelukast

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems